Skip to content

Trial of Different Hypothermia Temperatures in Patients Recovered From Out-of-hospital Cardiac Arrest

Pilot Randomized Clinical Trial Comparing the Efficacy of Two Different Hypothermia Temperatures for Treatment of Comatose Patients Recovered From an Out-of-hospital Cardiac Arrest

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01155622
Enrollment
36
Registered
2010-07-02
Start date
2008-03-31
Completion date
2012-05-31
Last updated
2012-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Arrest, Non-environmental Hypothermia

Keywords

Hypothermia, induced, Cardiac arrest, Disability evaluation, Cardiac arrhythmia, Ventricular function, Internal cooling, Out-of-hospital cardiac arrest, Post-cardiac arrest syndrome

Brief summary

Mild therapeutic hypothermia in the temperature range of 32º - 34ºC. improves survival in patients recovered from a ventricular fibrillation cardiac arrest. The same therapy is suggested with less evidence for asystole as first rhythm after cardiac arrest. The purpose of this study is to determine whether different temperature targets (32º vs 34º) may have different efficacy in the treatment of post-cardiac arrest patients. If successful, this pilot study will eventually form the basis for a larger, multicentric randomized clinical trial.

Detailed description

Patients admitted consecutively were potentially eligible for the study if they had a witnessed out-off hospital cardiac arrest (OHCA) apparently related to heart disease and an interval of \<60 minutes from collapse to return of spontaneous circulation (ROSC). Additional inclusion criteria were: 1. Age \>18 years. 2. Initial registered rhythm of a shockable rhythm (ventricular fibrillation or pulseless ventricular tachycardia) or asystole. Exclusion criteria were: 1. Known pregnancy 2. Glasgow Coma Scale score after ROSC \>8. 3. Cardiogenic shock (a systolic blood pressure of \<80 mm Hg despite inotrope infusion \>30 minutes). 4. Other nonshockable rhythms (pulseless electric activity). 5. Terminal illness present before the OHCA. 6. Possible causes of coma other than cardiac arrest (drug overdose, head trauma, or cerebrovascular accident).

Interventions

PROCEDUREEndovascular Cooling

Infusion of \<8°C cold saline followed by the implantation of the Icy 9.3F 38-cm catheter (ZOLL Medical Corporation, Chelmsford, MA) placed in the inferior vena cava through a femoral vein connected to the Thermogard XP Temperature Management System (ZOLL Medical Corporation). Cooling was set at a maximum rate with a target temperature of 32°C or 34°C according to randomization.

Sponsors

Hospital Universitario La Paz
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 18 * Resuscitated patients from a cardiac arrest with first rhythm of ventricular fibrillation or asystole * Witnessed cardiac arrest * Estimated delay between cardiac arrest and advanced resuscitation \< 20 min. * Resuscitation time from first contact to recovery of spontaneous circulation \< 60 min. * Hemodynamic stability (Mean blood pressure \[BP\] \>60 mmHg), with or without inotropic drugs, before randomization * Glasgow coma score \<9 without sedation before randomization

Exclusion criteria

* Pregnant women or suspected pregnancy or fertile women without a negative pregnancy test * Suspected non-cardiac arrest caused coma * Electrical instability (uncontrollable life-threatening arrhythmias) * Hemodynamic instability (Mean BP ≤60 mmHg), refractory to volume infusion or inotropic drugs * Refractory hypoxemia (saturation \<85% with FiO2=100%) * Previous known terminal illness * Active bleeding or known coagulopathy * Opposition from patient's family to enter the study

Design outcomes

Primary

MeasureTime frame
Survival free from severe dependence (Barthel index <60)6 months

Secondary

MeasureTime frameDescription
Survival at 6 months6 months
Barthel Index at 6 months6 months
Life threatening arrhythmias in different hypothermia temperatures48 hours (during hypothermia)New life-threatening arrhythmias during hypothermia: ventricular fibrillation, sustained (\>30 sec.) monomorphic or polymorphic ventricular tachycardia, extreme bradycardia (heart rate \<35 bpm. and/or pauses \>3 sec.)
Impact on ventricular function of different hypothermia temperatures48 hours During hypothermiaEchocardiographic evaluation of possible impact of different hypothermia temperatures on ventricular diastolic and systolic function

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 25, 2026